{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:53:23Z","timestamp":1776462803242,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073705"],"award-info":[{"award-number":["82073705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900331"],"award-info":[{"award-number":["81900331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970323"],"award-info":[{"award-number":["81970323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003644"],"award-info":[{"award-number":["82003644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019ZX09301148"],"award-info":[{"award-number":["2019ZX09301148"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biopha.2021.111874","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:36:21Z","timestamp":1625312181000},"page":"111874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-\u03baB signaling pathways"],"prefix":"10.1016","volume":"141","author":[{"given":"Weixin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaishou","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daona","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaozhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111874_bib1","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"22","key":"10.1016\/j.biopha.2021.111874_bib2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA-J. Am. Med. Assoc."},{"issue":"4","key":"10.1016\/j.biopha.2021.111874_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111874_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.111874_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jnutbio.2011.09.006","article-title":"The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease","volume":"23","author":"Nomura","year":"2012","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2021.111874_bib6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/hep.24003","article-title":"Activation of the endotoxin\/toll-like receptor 4 pathway: the way to go from nonalcoholic steatohepatitis up to hepatocellular carcinoma","volume":"53","author":"Alisi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.111874_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2019.101020","article-title":"A global perspective on the crosstalk between saturated fatty acids and Toll-like receptor 4 in the etiology of inflammation and insulin resistance","volume":"77","author":"Li","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111874_bib8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.biopha.2018.11.088","article-title":"A novel resveratrol-curcumin hybrid, a19, attenuates high fat diet-induced nonalcoholic fatty liver disease","volume":"110","author":"Wu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2021.111874_bib9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jcmm.13395","article-title":"Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease","volume":"22","author":"Zhang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2021.111874_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107308","article-title":"Therapeutic potential of bicyclol in liver diseases: lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine","volume":"91","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111874_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/molecules22040524","article-title":"Protective effect of bicyclol on anti-tuberculosis drug induced liver injury in rats","volume":"22","author":"Liu","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111874_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphar.2020.00463","article-title":"Bicyclol attenuates acute liver injury by activating autophagy, anti-oxidative and anti-inflammatory capabilities in mice","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111874_bib13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12885-016-2767-2","article-title":"Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K\/AKT and Ras\/Raf\/MEK\/ERK pathways","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2021.111874_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2021.111874_bib15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.111874_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.freeradbiomed.2017.01.023","article-title":"Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis","volume":"111","author":"Bellanti","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111874_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.biopha.2021.111874_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejphar.2016.06.040","article-title":"(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation","volume":"788","author":"Park","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111874_bib19","article-title":"Berberine ameliorates hepatic steatosis and suppresses liver and adipose tissue inflammation in mice with diet-induced obesity","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2021.111874_bib20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1478-3231.2005.01103.x","article-title":"Mechanism of protective action of bicyclol against CCl4-induced liver injury in mice","volume":"25","author":"Liu","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2021.111874_bib21","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.12659\/MSM.904090","article-title":"A multicenter and randomized controlled trial of bicyclol in the treatment of statin-induced liver injury","volume":"23","author":"Wu","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"10.1016\/j.biopha.2021.111874_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tox.2009.04.058","article-title":"Protective effect of bicyclol on tetracycline-induced fatty liver in mice","volume":"261","author":"Yu","year":"2009","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.biopha.2021.111874_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1478-3231.2011.02463.x","article-title":"Animal models in nonalcoholic steatohepatitis research: utility and clinical translation","volume":"31","author":"Anstee","year":"2011","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.biopha.2021.111874_bib24","doi-asserted-by":"crossref","first-page":"G270","DOI":"10.1152\/ajpgi.00304.2014","article-title":"Hepatic TLR4 signaling in obese NAFLD","volume":"309","author":"Sharifnia","year":"2015","journal-title":"Am. J. Physiol. Gastroint. Liver Physiol."},{"key":"10.1016\/j.biopha.2021.111874_bib25","article-title":"Author Correction: saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2021.111874_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2015.09.005","article-title":"CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy","volume":"64","author":"Zhang","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2021.111874_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34633-y","article-title":"Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model","volume":"8","author":"Henkel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111874_bib28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fphar.2020.00530","article-title":"Si-Wei-Qing-Gan-Tang improves non-alcoholic steatohepatitis by modulating the nuclear factor-\u03bab signal pathway and autophagy in methionine and choline deficient diet-fed rats","volume":"11","author":"Xiao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111874_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.intimp.2019.02.024","article-title":"Protective effects of levo-tetrahydropalmatine on hepatic ischemia\/reperfusion injury are mediated by inhibition of the ERK\/NF-kappa B pathway","volume":"70","author":"Yu","year":"2019","journal-title":"Int. Immunopharmacol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2025.118888","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000}},{"DOI":"10.1016\/j.biopha.2025.118888","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:10:19Z","timestamp":1776460219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221006569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":29,"alternative-id":["S0753332221006569"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111874","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-\u03baB signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111874"}}